MedPath

Clinical research for relationship between serum IL-31 and pruritus in patients who undergo hemodialysis

Not Applicable
Completed
Conditions
hemodialysis
Registration Number
JPRN-jRCT1080224513
Lead Sponsor
Chugai Pharmaceutical Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Personally provided written informed consent for the clinical study and able to comply with the requirements of the study protocol
- Aged =>20 and <75 years old at the time of informed consent
- Has undergone hemodialysis (including hemodiafiltration) 3 times a week for at least 12 weeks before enrollment

Exclusion Criteria

- Deemed unsuitable as a subject in the study by the investigator for some other reason

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath